Evaluation of (188)Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model

PURPOSE: In this study, the (188)Re-labeled PEGylated nanoliposome ((188)Re-liposome) was prepared and evaluated as a therapeutic agent for glioma. MATERIALS AND METHODS: The reporter cell line, F98(luc) was prepared via Lentivector expression kit system and used to set up the orthotopic glioma-bear...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Feng-Yun J, Lee, Te-Wei, Chang, Chih-Hsien, Chen, Liang-Cheng, Hsu, Wei-Hsin, Chang, Chien-Wen, Lo, Jem-Mau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296959/
https://www.ncbi.nlm.nih.gov/pubmed/25624760
http://dx.doi.org/10.2147/IJN.S75955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296959/
https://www.ncbi.nlm.nih.gov/pubmed/25624760
http://dx.doi.org/10.2147/IJN.S75955

Ejemplares similares